Search

everythinglearnresearchcommunity

for

Search:↓

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

3D virtual planning can help in precise skull reconstruction for advanced skin cancer, but patient-specific factors must be considered.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

The document listed medical job ads and guidelines for breast cancer screening.

The combination treatment showed a higher response rate but no significant survival benefits.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.